At Precision Eye Care, our highest priority is making sure our patients have healthy eyes and clear vision. We offer a full range of vision correction options, including EVO ICLTM lens (EVO) for our patients who want to break free from the hassles of glasses and contacts.
Request a Free Consultation:
What is EVO ICL?
EVO ICL, also called an Implantable Collamer® Lens, is a refractive implant to correct common vision issues like myopia (nearsightedness) with or without astigmatism. Unlike some other vision correction options, the EVO ICL is an additive technology that corrects vision without the removal of any corneal tissue. The EVO ICL is meant to reduce or eliminate the need for glasses and contact lenses and unlike most permanent refractive surgery solutions, EVO ICL is removable by your doctor, for added peace of mind.
Easy 20-30 Minute Surgical Procedure
Pre-Op Eye Exam
Eye Drops Administered
Small Opening
Lens Insertion and Positioning
Post Op & Check-up
What is Recovery Like after EVO ICL?
Most patients notice a dramatic improvement in their vision nearly immediately after their EVO ICL vision correction surgery. Recovery is brief and comfortable for most, with many patients returning to work the very next day.
Benefits of EVO ICL:
- Provides sharp, clear vision
- 20 to 30 minute procedure
- Quick recovery time
- Removable by your ophthalmologist
- Offers UV protection
- Not visible once in place
- Can treat nearsightedness (myopia) with or without astigmatism
For patients who may not be candidates for LASIK or other vision correction procedures due to thin corneas:
- Does not cause or worsen dry eye syndrome
- Exceptional vision both day and night
- Over 3 million ICLs distributed world-wide
- 99.4% of patients surveyed would have the EVO ICL lens procedure again
Cost and Financing for EVO ICL
The cost of an EVO ICL procedure can vary depending on your personalized treatment plan. Many EVO ICL patients
look forward to spending less in the long run with the EVO ICL compared to the continued costs of contact lenses and glasses. Ask about financing options and payment plans that may be available for your EVO ICL procedure.
“With Visian ICL my eyes are now clearer than they have ever been at night.”
– Phil, Biologist
“It’s as if my eyesight was never any issue; it’s just simply better.”
– Puno, App Designer
Book your consultation.
Contact your eye doctor to discuss if EVO ICL is right for you.
Important Safety Information for EVO ICL
The EVO Visian ICL lens is intended to correct/reduce nearsightedness between -3.0 D up to -20.0 D and treat astigmatism from 1.0 D to 4.0 D. If you have nearsightedness within these ranges, EVO Visian ICL surgery may improve your distance vision without eyeglasses or contact lenses. Because the EVO Visian ICL corrects for distance vision, it does not eliminate the need for reading glasses, you may require them at some point, even if you have never worn them before. Since implantation of the EVO Visian ICL is a surgical procedure, before considering EVO Visian ICL surgery you should have a complete eye examination and talk with your eye care professional about EVO Visian ICL surgery, especially the potential benefits, risks, and complications. You should discuss the time needed for healing after surgery. Complications, although rare, may include need for additional surgical procedures, inflammation, loss of cells from the back surface of the cornea, increase in eye pressure, and cataracts. You should NOT have EVO Visian ICL surgery if your doctor determines that 1) the shape of your eye is not appropriate, 2) you do not meet the minimum endothelial cell density for your age at the time of implantation, 3) you have moderate to severe glaucoma, 4) your vision is not stable; or 5) if you are pregnant or nursing.
For additional information with potential benefits, risks and complications please visit DiscoverICL.com
Martínez-Plaza E, López-Miguel A, López-de la Rosa A, et al. Effect of the EVO+ Visian Phakic Implantable Collamer Lens on Visual Performance and Quality of Vision and Life, Am J Ophthalmol 2021;226:117-125. 2 Packer M. Evaluation of the EVO/EVO+ Sphere and Toric Visian ICL: Six month results from the United States Food and Drug Administration clinical trial. Clinical Ophthalmology. 2022;16:1541-53. 3 Parkhurst G, Psolka M, Kezirian G. Phakic intraocular lens implantation in United States military warfighters: A retrospective analysis of early clinical outcomes of the Visian ICL. J Refract Surg. 2011;27(7):473-481 4 Ganesh S, Brar S, Pawar A. Matched population comparison of visual outcomes and patient satisfaction between 3 modalities for the correction of low to moderate myopic astigmatism. Clin Ophthalmol. 2017 Jul 3;11:1253-1263. 5 Naves J.S, Carracedo G, Cacho-Babillo I, Diadenosine nucleotid measurements as dry-eye score in patients after LASIK and ICL surgery. Presented at American Society of Cataract and Refractive Surgery (ASCRS) 2012. 6 Parkhurst GD. A prospective comparison of phakic collamer lenses and wavefront-optimized laser-assisted in situ keratomileusis for correction of myopia. Clin Ophthalmol. 2016;10:1209-1215. 7 Packer M. The Implantable Collamer Lens with a central port: review of the literature. Clin Ophthalmol. 2018;12:2427-2438.
